These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options. Chen N; Diao CY; Gao J; Zhao DB Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis. Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064 [TBL] [Abstract][Full Text] [Related]
9. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? de Lauretis A; Veeraraghavan S; Renzoni E Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375 [TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A; Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887 [TBL] [Abstract][Full Text] [Related]
12. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival. Yunt ZX; Chung JH; Hobbs S; Fernandez-Perez ER; Olson AL; Huie TJ; Keith RC; Janssen WJ; Goldstein BL; Lynch DA; Brown KK; Swigris JJ; Solomon JJ Respir Med; 2017 May; 126():100-104. PubMed ID: 28427540 [TBL] [Abstract][Full Text] [Related]
13. The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China. Wang N; Zhang Q; Jing X; Guo J; Huang H; Xu Z Med Sci Monit; 2020 Mar; 26():e920137. PubMed ID: 32142504 [TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Xie M; Zhu C; Ye Y BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169 [TBL] [Abstract][Full Text] [Related]
15. Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD). Yu M; Guo Y; Zhang P; Xue J; Yang J; Cai Q; You X; Ma J; Yang D; Jia Y; Wang Y; Li F; Chi S; Cao M; Chen J; Liu X Immunobiology; 2019 Jul; 224(4):551-559. PubMed ID: 31072629 [TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060 [TBL] [Abstract][Full Text] [Related]
17. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586 [TBL] [Abstract][Full Text] [Related]